Journal Logo

Articles by I. Galtseva

PD-1 PATHWAY IS A KEY IMMUNOSUPPRESSIVE MECHANISM IN PATIENTS AFTER HAPLOIDENTICAL STEM CELL TRANSPLANTATION WITH TCR AB-DEPLETION: PF755

Popova, N.; Drokov, M.; Davydova, Y.; More

HemaSphere. 3:331-332, June 2019.

RESULTS OF TREATMENT PATIENTS OF MANTLE CELL LYMPHOMA DEPENDING ON THE MUTATIONAL STATUS OF THE TP53 GENE: PB2016

Koroleva, D.; Zvonkov, E.; Gabeeva, N.; More

HemaSphere. 3:912, June 2019.